Related references
Note: Only part of the references are listed.Accurate and efficient detection of gene fusions from RNA sequencing data
Sebastian Uhrig et al.
GENOME RESEARCH (2021)
A community challenge to evaluate RNA-seq, fusion detection, and isoform quantification methods for cancer discovery
Allison Creason et al.
CELL SYSTEMS (2021)
ArtiFuse-computational validation of fusion gene detection tools without relying on simulated reads
Patrick Sorn et al.
BIOINFORMATICS (2020)
Pan-cancer analysis of whole genomes
Peter J. Campbell et al.
NATURE (2020)
Commensal bacteria stimulate antitumor responses via T cell cross-reactivity
Catherine A. Bessell et al.
JCI INSIGHT (2020)
Pre-existing heterologous T-cell immunity and neoantigen immunogenicity
Qibin Leng et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2020)
Diagnosis of fusion genes using targeted RNA sequencing
Erin E. Heyer et al.
NATURE COMMUNICATIONS (2019)
Immunogenic neoantigens derived from gene fusions stimulate T cell responses
Wei Yang et al.
NATURE MEDICINE (2019)
Neoantigen Dissimilarity to the Self-Proteome Predicts Immunogenicity and Response to Immune Checkpoint Blockade
Lee P. Richman et al.
CELL SYSTEMS (2019)
Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods
Brian J. Haas et al.
GENOME BIOLOGY (2019)
Comprehensive evaluation of structural variation detection algorithms for whole genome sequencing
Shunichi Kosugi et al.
GENOME BIOLOGY (2019)
Improved methods for predicting peptide binding affinity to MHC class II molecules
Kamilla Kjaergaard Jensen et al.
IMMUNOLOGY (2018)
Personalized vaccines for cancer immunotherapy
Ugur Sahin et al.
SCIENCE (2018)
Driver Fusions and Their Implications in the Development and Treatment of Human Cancers
Qingsong Gao et al.
CELL REPORTS (2018)
NetMHCpan-4.0: Improved Peptide-MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data
Vanessa Jurtz et al.
JOURNAL OF IMMUNOLOGY (2017)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
Vinod P. Balachandran et al.
NATURE (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
Identification of KANSARL as the first cancer predisposition fusion gene specific to the population of European ancestry origin
Jeff Xiwu Zhou et al.
ONCOTARGET (2017)
An Analysis of Natural T Cell Responses to Predicted Tumor Neoepitopes
Anne-Mette Bjerregaard et al.
FRONTIERS IN IMMUNOLOGY (2017)
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity
Matthew T. Chang et al.
NATURE BIOTECHNOLOGY (2016)
Recurrent chimeric fusion RNAs in non-cancer tissues and cells
Mihaela Babiceanu et al.
NUCLEIC ACIDS RESEARCH (2016)
Targeting of cancer neoantigens with donor-derived T cell receptor repertoires
Erlend Stronen et al.
SCIENCE (2016)
Read-through transcripts in normal human lung parenchyma are down-regulated in lung adenocarcinoma
Giulia Pintarelli et al.
ONCOTARGET (2016)
InFusion: Advancing Discovery of Fusion Genes and Chimeric Transcripts from Deep RNA-Sequencing Data
Konstantin Okonechnikov et al.
PLOS ONE (2016)
NTRK gene fusions as novel targets of cancer therapy across multiple tumour types
Alessio Amatu et al.
ESMO OPEN (2016)
T Cell Receptor Cross-Reactivity between Similar Foreign and Self Peptides Influences Naive Cell Population Size and Autoimmunity
Ryan W. Nelson et al.
IMMUNITY (2015)
A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
Beatriz M. Carreno et al.
SCIENCE (2015)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Lessons from the Cancer Genome
Levi A. Garraway et al.
CELL (2013)
SOAPfuse: an algorithm for identifying fusion transcripts from paired-end RNA-Seq data
Wenlong Jia et al.
GENOME BIOLOGY (2013)
Primer3-new capabilities and interfaces
Andreas Untergasser et al.
NUCLEIC ACIDS RESEARCH (2012)
Reanalysis of RNA-Sequencing Data Reveals Several Additional Fusion Genes with Multiple Isoforms
Sara Kangaspeska et al.
PLOS ONE (2012)
HLA typing from RNA-Seq sequence reads
Sebastian Boegel et al.
GENOME MEDICINE (2012)
RNA-Seq Mapping and Detection of Gene Fusions with a Suffix Array Algorithm
Onur Sakarya et al.
PLOS COMPUTATIONAL BIOLOGY (2012)
Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer
Dan R. Robinson et al.
NATURE MEDICINE (2011)
A novel bioinformatics pipeline for identification and characterization of fusion transcripts in breast cancer and normal cell lines
Yan W. Asmann et al.
NUCLEIC ACIDS RESEARCH (2011)
Identification of fusion genes in breast cancer by paired-end RNA-sequencing
Henrik Edgren et al.
GENOME BIOLOGY (2011)
MapSplice: Accurate mapping of RNA-seq reads for splice junction discovery
Kai Wang et al.
NUCLEIC ACIDS RESEARCH (2010)
Transcriptome sequencing to detect gene fusions in cancer
Christopher A. Maher et al.
NATURE (2009)
Enhancements and modifications of primer design program Primer3
Triinu Koressaar et al.
BIOINFORMATICS (2007)
Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells
Silke Holtkamp et al.
BLOOD (2006)
Identification and epitope enhancement of a PAX-FKHR fusion protein breakpoint epitope in alveolar rhabdomyosarcoma cells created by a tumorigenic chromosomal translocation inducing CTL capable of lysing human tumors
LT van den Broeke et al.
CANCER RESEARCH (2006)
Mature dendritic cells derived from human monocytes within 48 hours: A novel strategy for dendritic cell differentiation from blood precursors
M Dauer et al.
JOURNAL OF IMMUNOLOGY (2003)
Leukemia-associated fusion proteins, dek-can and bcr-abl, represent immunogenic HLA-DR-restricted epitopes recognized by fusion peptide-specific CD4+ T lymphocytes
M Makita et al.
LEUKEMIA (2002)
Detection and induction of CTLs specific for SYT-SSX-derived peptides in HLA-A24+ patients with synovial sarcoma
Y Sato et al.
JOURNAL OF IMMUNOLOGY (2002)
Share Paper
